Stage Four Advanced Metastatic Cancer Step Therapy

The bill prohibits a carrier that issues a health benefit plan that covers treatment for stage four advanced metastatic cancer from requiring a cancer patient to undergo step therapy prior to receiving a drug approved by the United States food and drug administration if use of the approved drug is consistent with best practices for treatment of the cancer and as long as the drug is on the carrier's prescription drug formulary. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) , Read More